Grippe-Pandemie und Tamiflu-Produktion
The media briefing has taken place at Roche's headquarters in Basel on 9 November 2005.
William M. Burns, CEO Division Pharmaceuticals, Roche
Prof. John Oxford, Queen Mary’s University of London
Eugene Tierney, Global Head Virology and Transplantation, Roche
David Reddy, Influenza Pandemic Taskforce Leader, Roche
Roche pandemic strategy (4.5 MB)
Jan van Koeveringe, Head Pharma Global Technical Operations, Roche
The challenges of Tamiflu manufacturing